Cancer Genomics & Metabolomics


A branch of genomics called oncogenomics studies the characteristics of genes that are connected to or associated with cancer. It mainly focuses on transcript, epigenomic, and genomic changes in cancer. Oncogenomics' major goal is to identify new oncogenes or tumour suppressor genes that could open up new avenues for study into cancer diagnosis, cancer prognosis, and potential new targets for cancer treatments. Targeted cancer medicines like GleevecHerceptin, and Avastin have made it possible for oncogenomics to identify novel cancer therapeutic targets. The term "metabolomics" refers to the entire range of small-molecule metabolites, which allows for the systematic analysis of distinct chemical fingerprints that leave cellular activities in the dust. It is a relatively young topic of "omics" research. The collection is represented by the metabolome.



 


    Related Conference of Cancer Genomics & Metabolomics

    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 26-27, 2025

    15th World Congress on Breast Cancer

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 13-14, 2025

    8th International Conference on Anti-Cancer Drugs & Therapies

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain

    Cancer Genomics & Metabolomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in